Does VISMODEGIB Cause Salivary hypersecretion? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Salivary hypersecretion have been filed in association with VISMODEGIB (ERIVEDGE). This represents 0.1% of all adverse event reports for VISMODEGIB.
8
Reports of Salivary hypersecretion with VISMODEGIB
0.1%
of all VISMODEGIB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Salivary hypersecretion From VISMODEGIB?
Of the 8 reports, 1 (12.5%) required hospitalization.
Is Salivary hypersecretion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VISMODEGIB. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does VISMODEGIB Cause?
Muscle spasms (1,937)
Alopecia (1,330)
Ageusia (958)
Fatigue (899)
Dysgeusia (706)
Weight decreased (688)
Nausea (669)
Decreased appetite (662)
Death (657)
Diarrhoea (446)
What Other Drugs Cause Salivary hypersecretion?
CLOZAPINE (1,349)
ARIPIPRAZOLE (497)
RISPERIDONE (485)
OLANZAPINE (449)
QUETIAPINE (299)
CARBIDOPA\LEVODOPA (248)
HALOPERIDOL (216)
DIAZEPAM (185)
CLONAZEPAM (179)
LORAZEPAM (165)
Which VISMODEGIB Alternatives Have Lower Salivary hypersecretion Risk?
VISMODEGIB vs VITAMIN A
VISMODEGIB vs VITAMIN B
VISMODEGIB vs VITAMIN D NOS
VISMODEGIB vs VITAMINS
VISMODEGIB vs VOCLOSPORIN